Publication: Deciphering the elevated lipid via cd36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based fourier transform infrared spectroscopy of single cells
Issued Date
2019-04-01
Resource Type
ISSN
20726694
Other identifier(s)
2-s2.0-85065410837
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cancers. Vol.11, No.4 (2019)
Suggested Citation
Sudjit Luanpitpong, Montira Janan, Kanjana Thumanu, Jirarat Poohadsuan, Napachai Rodboon, Phatchanat Klaihmon, Surapol Issaragrisil Deciphering the elevated lipid via cd36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based fourier transform infrared spectroscopy of single cells. Cancers. Vol.11, No.4 (2019). doi:10.3390/cancers11040576 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/50215
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Deciphering the elevated lipid via cd36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based fourier transform infrared spectroscopy of single cells
Abstract
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. Despite overall progress in improving cancer treatments, the complete response of mantle cell lymphoma (MCL) is still limited due to the inevitable development of drug resistance. More than half of patients did not attain response to bortezomib (BTZ), the approved treatment for relapsed or refractory MCL. Understanding how MCL cells acquire BTZ resistance at the molecular level may be a key to the long-term management of MCL patients and new therapeutic strategies. We established a series of de novo BTZ-resistant human MCL-derived cells with approximately 15- to 60-fold less sensitivity than those of parental cells. Using gene expression profiling, we discovered that putative cancer-related genes involved in drug resistance and cell survival tested were mostly downregulated, likely due to globalDNAhypermethylation. Significant information on dysregulated lipid metabolism was obtained from synchrotron-based Fourier transform infrared (FTIR) spectroscopy of single cells. We demonstrated for the first time an upregulation of CD36 in highly BTZ-resistant cells in accordance with an increase in their lipid accumulation. Ectopic expression of CD36 causes an increase in lipid droplets and renders BTZ resistance to various human MCL cells. By contrast, inhibition of CD36 by neutralizing antibody strongly enhances BTZ sensitivity, particularly in CD36-overexpressing cells and de novo BTZ-resistant cells. Together, our findings highlight the potential application of CD36 inhibition for BTZ sensitization and suggest the use of FTIR spectroscopy as a promising technique in cancer research.